Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive form of inherited ichthyosis.
Biomarker and diagnostic research for autosomal recessive congenital ichthyosis has been reported in the published literature.
No approved treatments are currently available for autosomal recessive congenital ichthyosis. An additional 1 compound holds orphan drug designation.
While no drugs are FDA-approved specifically for autosomal recessive congenital ichthyosis, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.
The following drugs have received orphan drug designation from the FDA for autosomal recessive congenital ichthyosis. Orphan designation reflects regulatory interest and does not indicate approval for treatment.
Brand Name | Generic Name | Sponsor |
|---|
Estimated prevalence: 1-9 in 1,000,000 (Rare).
No clinical trials have been registered for autosomal recessive congenital ichthyosis.
54 publications have been identified in PubMed for autosomal recessive congenital ichthyosis. Research spans Case Report / Case Series (53%), Review / Meta-Analysis (12%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 27 | 53% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:02 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Designated
Exclusivity End |
|---|
Designation Status |
|---|
A replication-incompetent, non-integrating Herpes simplex type 1 (HSV-1) vector expressing the human transglutaminase-1 (TGM-1) enzyme | A replication-incompetent, non-integrating Herpes simplex type 1 (HSV-1) vector expressing the human transglutaminase-1 (TGM-1) enzyme | Krystal Biotech, Inc. | 2018 | — | Designated |
Gene therapy approaches for autosomal recessive congenital ichthyosis have been reported in the published literature.
View trials for autosomal recessive congenital ichthyosis
Research summaries
6 |
12% |
Laboratory research | 5 | 10% |
Other research | 4 | 8% |
Disease patterns and progression | 4 | 8% |
New treatment approaches | 3 | 6% |
Testing and diagnosis research | 1 | 2% |
Clinical study results | 1 | 2% |
Apaydin DC (2026). [PMID: 41605220](https://pubmed.ncbi.nlm.nih.gov/41605220/). *Cell Stem Cell*. [Gene Therapy / Novel Therapeutics]
Tsai AC (2026). [PMID: 41859732](https://pubmed.ncbi.nlm.nih.gov/41859732/). *Mol Genet Metab Rep*. [Case Report / Case Series]
Tajiri M (2026). [PMID: 41220238](https://pubmed.ncbi.nlm.nih.gov/41220238/). *J Dermatol*. [Case Report / Case Series]
Elgie T (2026). [PMID: 42001132](https://pubmed.ncbi.nlm.nih.gov/42001132/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Peng Y (2026). [PMID: 41964248](https://pubmed.ncbi.nlm.nih.gov/41964248/). *J Dermatol*. [Basic Science / Preclinical]
Palanki R (2026). [PMID: 41650933](https://pubmed.ncbi.nlm.nih.gov/41650933/). *Cell Stem Cell*. [Other]
Kumar A (2026). [PMID: 41949191](https://pubmed.ncbi.nlm.nih.gov/41949191/). *Indian J Dermatol Venereol Leprol*. [Case Report / Case Series]
Jiang X (2026). [PMID: 41530952](https://pubmed.ncbi.nlm.nih.gov/41530952/). *Br J Dermatol*. [Case Report / Case Series]
Petruzzelli R (2026). [PMID: 41213165](https://pubmed.ncbi.nlm.nih.gov/41213165/). *Physiology (Bethesda)*. [Review / Meta-Analysis]
Elendu C (2026). [PMID: 42052316](https://pubmed.ncbi.nlm.nih.gov/42052316/). *Clin Case Rep*. [Case Report / Case Series]
AI-curated news mentioning autosomal recessive congenital ichthyosis
Updated Sep 4, 2026
A new study explores CYP4F22-related autosomal recessive congenital ichthyosis, highlighting its association with Hirschsprung disease and Bartter-like renal manifestations. This research adds to the understanding of genetic links between these rare conditions.